Machine learning technology, especially deep learning, which has rapidly developed mainly in image and language processing, has been widely applied to medical data analysis. Recently, diagnostic systems that recognize patients with high accuracy have ...
Machine learning technology, especially deep learning, which has rapidly developed mainly in image and language processing, has been widely applied to medical data analysis. Recently, diagnostic systems that recognize patients with high accuracy have been developed based on various types of medical images, such as radiation and ultrasound imaging. Medical imaging, such as computed tomography and magnetic resonance imaging (MRI), is widely used to diagnose brain disorders. These imaging systems capture the structure of the brain to find structural brain abnormalities. On the other hand, an electroencephalogram (EEG) and functional MRI are mainly used to measure the functional activity of the brain. An EEG is a time-series signal that records the electrical activity of the cerebral cortex using electrodes attached to the scalp. EEGs are mainly used in the field of cognitive neuroscience because they are effective in tracking rapid temporal changes in brain activity when performing cognitive tasks. However, determining which cerebral area exhibits abnormalities is difficult due to the low spatial resolution of an EEG.
This study, therefore, aimed to develop an explainable machine learning-based EEG analysis system. The system estimated cortical activity from an EEG through source localization to resolve poor spatial resolution and generate images. Then, the system was designed to diagnose and examine patients with sleep-related brain disorders based on these images.
The developed system was applied to experimental data for verification. Up to 99% accuracy was achieved in distinguishing patients from normal controls using multichannel EEG recorded during a cognitive task. The abnormal brain activity characteristics of patients were closely related to cognitive impairment. In addition, the developed system classified most brain activity in patients who received medication as normal. The degree of normalization of brain activity was associated with improved symptoms and sleep quality in the patients.
The developed system could be used for diagnosis and treatment monitoring for patients with sleep-related brain disorders. Furthermore, the system might be able to predict treatment response or the possibility of transition in neurodegenerative diseases.